These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 20615620
1. Sodium selenite radiosensitizes hormone-refractory prostate cancer xenograft tumors but not intestinal crypt cells in vivo. Tian J, Ning S, Knox SJ. Int J Radiat Oncol Biol Phys; 2010 Sep 01; 78(1):230-6. PubMed ID: 20615620 [Abstract] [Full Text] [Related]
2. Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer. Bhattacharyya RS, Husbeck B, Feldman D, Knox SJ. Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):935-40. PubMed ID: 18760546 [Abstract] [Full Text] [Related]
6. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway. Zhang AL, Russell PJ, Knittel T, Milross C. Prostate; 2007 Nov 01; 67(15):1630-40. PubMed ID: 17823933 [Abstract] [Full Text] [Related]
7. Metabolic response of the CWR22 prostate tumor xenograft after 20 Gy of radiation studied by 1H spectroscopic imaging. Dyke JP, Zakian KL, Spees WM, Matei C, Chen Y, Mao X, Shungu DC, Koutcher JA. Clin Cancer Res; 2003 Oct 01; 9(12):4529-36. PubMed ID: 14555527 [Abstract] [Full Text] [Related]
8. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Pederson LC, Buchsbaum DJ, Vickers SM, Kancharla SR, Mayo MS, Curiel DT, Stackhouse MA. Cancer Res; 1997 Oct 01; 57(19):4325-32. PubMed ID: 9331094 [Abstract] [Full Text] [Related]
9. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. Samsel L, Zaidel G, Drumgoole HM, Jelovac D, Drachenberg C, Rhee JG, Brodie AM, Bielawska A, Smyth MJ. Prostate; 2004 Mar 01; 58(4):382-93. PubMed ID: 14968439 [Abstract] [Full Text] [Related]
10. CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity. Chen Y, DeWeese T, Dilley J, Zhang Y, Li Y, Ramesh N, Lee J, Pennathur-Das R, Radzyminski J, Wypych J, Brignetti D, Scott S, Stephens J, Karpf DB, Henderson DR, Yu DC. Cancer Res; 2001 Jul 15; 61(14):5453-60. PubMed ID: 11454691 [Abstract] [Full Text] [Related]
11. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice. Zheng X, Chang RL, Cui XX, Avila GE, Hebbar V, Garzotto M, Shih WJ, Lin Y, Lu SE, Rabson AB, Kong AN, Conney AH. Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3444-51. PubMed ID: 16740769 [Abstract] [Full Text] [Related]
13. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. Feeley BT, Gamradt SC, Hsu WK, Liu N, Krenek L, Robbins P, Huard J, Lieberman JR. J Bone Miner Res; 2005 Dec 01; 20(12):2189-99. PubMed ID: 16294272 [Abstract] [Full Text] [Related]